Skip to main content
Smart Investors Daily
CO

NYSE · CO

Global Cord Blood Corporation

Healthcare · Medical - Diagnostics & Research

$2.99

Up+$0.00 (+0.00%)

Updated Sep 15, 2026, 2:06 PM

SID Score

Composite research score

Smart Money

Institutional and insider signal

Market cap
400.08M
P/E ratio
1.28
Dividend yield
0.00%
52-week range
— – —
Volume
0
Avg. volume
178.18K

Price performance

CO price history

1M range · 0 trading sessions · Daily adjusted prices

CO does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest CO news

The latest Smart Investors Daily articles mentioning CO.

CO research

Overview

Company profile and research snapshot.

Company profile

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.